Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 1 · 100%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Malignancy · adults and children who have IgA nephropathy proven on renal biopsy

It is very uncertain whether mizoribine regimen changes malignancy compared with no mizoribine regimen (very low certainty).

1 finding from 1 review

Immunosuppressive agents for treating IgA nephropathy 2020 · Cochrane Headline outcomes only
RR 3 [0.13, 69.7]
1 study · 42 participants
Very low